Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis

Journal of Cell Biology

Volumn 208, Issue 1, 2015, Pages 125-136

  Zou, Wei ^a   Teitelbaum, Steven L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; PROTEIN KINASE SYK; VITRONECTIN RECEPTOR; BETA3 INTEGRIN; CELL SURFACE RECEPTOR; FC RECEPTOR; OSCAR PROTEIN, MOUSE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROBP PROTEIN, MOUSE;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GENE DELETION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRABECULAR BONE; ANIMAL; BONE DENSITY; CELL CULTURE; COCULTURE; DEFICIENCY; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; OSTEOPOROSIS; PATHOLOGY; PHOSPHORYLATION; SEVERITY OF ILLNESS INDEX;

MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BONE DENSITY; BONE RESORPTION; CELLS, CULTURED; COCULTURE TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; INTEGRIN ALPHAVBETA3; INTEGRIN BETA3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPOROSIS; PHENOTYPE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; SEVERITY OF ILLNESS INDEX; TRANSFECTION;

EID: 84920915313     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201410123     Document Type: Article

References (26)

1. Barrow, A.D., N. Raynal, T.L. Andersen, D.A. Slatter, D. Bihan, N. Pugh, M. Cella, T. Kim, J. Rho, T. Negishi-Koga, et al. 2011. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J. Clin. Invest. 121:3505-3516. http://dx.doi.org/10.1172/JCI45913.
2. Calderwood, D.A., V. Tai, G. Di Paolo, P. De Camilli, and M.H. Ginsberg. 2004. Competition for talin results in trans-dominant inhibition of integrin activation. J. Biol. Chem. 279:28889-28895. http://dx.doi.org/10.1074/jbc.M402161200.
3. Croke, M., F.P. Ross, M. Korhonen, D.A. Williams, W. Zou, and S.L. Teitelbaum. 2011. Rac deletion in osteoclasts causes severe osteopetrosis. J. Cell Sci. 124:3811-3821. http://dx.doi.org/10.1242/jcs.086280.
4. Das, M., S. Subbayya Ithychanda, J. Qin, and E.F. Plow. 2014. Mechanisms of talin-dependent integrin signaling and crosstalk. Biochim. Biophys. Acta. 1838:579-588.
5. Faccio, R., D.V. Novack, A. Zallone, F.P. Ross, and S.L. Teitelbaum. 2003a. Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin. J. Cell Biol. 162:499-509. http://dx.doi.org/10.1083/jcb.200212082.
6. Faccio, R., W. Zou, G. Colaianni, S.L. Teitelbaum, and F.P. Ross. 2003b. High dose M-CSF partially rescues the Dap12-/-osteoclast phenotype. J. Cell. Biochem. 90:871-883. http://dx.doi.org/10.1002/jcb.10694.
7. Helfrich, M.H., S.A. Nesbitt, P.T. Lakkakorpi, M.J. Barnes, S.C. Bodary, G. Shankar, W.T. Mason, D.L. Mendrick, H.K. Väänänen, and M.A. Horton. 1996. Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone. 19:317-328. http://dx.doi.org/10.1016/S8756-3282(96)00223-2.
8. Humphrey, M.B., L.L. Lanier, and M.C. Nakamura. 2005. Role of ITAMcontaining adapter proteins and their receptors in the immune system and bone. Immunol. Rev. 208:50-65. http://dx.doi.org/10.1111/j.0105-2896.2005.00325.x.
9. Ishikawa, S., N. Arase, T. Suenaga, Y. Saita, M. Noda, T. Kuriyama, H. Arase, and T. Saito. 2004. Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR). Int. Immunol. 16:1019-1025. http://dx.doi.org/10.1093/intimm/dxh103.
10. Kaifu, T., J. Nakahara, M. Inui, K. Mishima, T. Momiyama, M. Kaji, A. Sugahara, H. Koito, A. Ujike-Asai, A. Nakamura, et al. 2003. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J. Clin. Invest. 111:323-332. http://dx.doi.org/10.1172/JCI16923.
11. Kamiguti, A.S., R.D. Theakston, S.P. Watson, C. Bon, G.D. Laing, and M. Zuzel. 2000. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation. Arch. Biochem. Biophys. 374:356-362. http://dx.doi.org/10.1006/abbi.1999.1627.
12. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 428:758-763. http://dx.doi.org/10.1038/nature02444.
13. Lam, J., S. Takeshita, J.E. Barker, O. Kanagawa, F.P. Ross, and S.L. Teitelbaum. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106:1481-1488. http://dx.doi.org/10.1172/JCI11176.
14. McHugh, K.P., K. Hodivala-Dilke, M.H. Zheng, N. Namba, J. Lam, D. Novack, X. Feng, F.P. Ross, R.O. Hynes, and S.L. Teitelbaum. 2000. Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105:433-440. http://dx.doi.org/10.1172/JCI8905.
15. Mócsai, A., M.B. Humphrey, J.A. Van Ziffle, Y. Hu, A. Burghardt, S.C. Spusta, S. Majumdar, L.L. Lanier, C.A. Lowell, and M.C. Nakamura. 2004. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA. 101:6158-6163. http://dx.doi.org/10.1073/pnas.0401602101.
16. Murphy, M.G., K. Cerchio, S.A. Stoch, K. Gottesdiener, M. Wu, and R. Recker. L-000845704 Study Group. 2005. Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J. Clin. Endocrinol. Metab. 90:2022-2028. http://dx.doi.org/10.1210/jc.2004-2126.
17. Novack, D.V., and S.L. Teitelbaum. 2008. The osteoclast: friend or foe? Annu. Rev. Pathol. 3:457-484. http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151431.
18. Schmidt, S., I. Nakchbandi, R. Ruppert, N. Kawelke, M.W. Hess, K. Pfaller, P. Jurdic, R. Fässler, and M. Moser. 2011. Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. J. Cell Biol. 192:883-897. http://dx.doi.org/10.1083/jcb.201007141.
19. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:693-702. http://dx.doi.org/10.1016/0092-8674(91)90499-O.
20. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J.V. Ravetch. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 76:519-529. http://dx.doi.org/10.1016/0092-8674(94)90115-5.
21. Tolar, J., S.L. Teitelbaum, and P.J. Orchard. 2004. Osteopetrosis. N. Engl. J. Med. 351:2839-2849. http://dx.doi.org/10.1056/NEJMra040952.
22. Williams, D.S., P.J. McCracken, M. Purcell, M. Pickarski, P.D. Mathers, A.T. Savitz, J. Szumiloski, R.Y. Jayakar, S. Somayajula, S. Krause, et al. 2013. Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate. Bone. 56:489-496. http://dx.doi.org/10.1016/j.bone.2013.06.008.
23. Zou, W., H. Kitaura, J. Reeve, F. Long, V.L.J. Tybulewicz, S.J. Shattil, M.H. Ginsberg, F.P. Ross, and S.L. Teitelbaum. 2007. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176:877-888. http://dx.doi.org/10.1083/jcb.200611083.
24. Zou, W., J.L. Reeve, Y. Liu, S.L. Teitelbaum, and F.P. Ross. 2008. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol. Cell. 31:422-431. http://dx.doi.org/10.1016/j.molcel.2008.06.023.
25. Zou, W., T. Zhu, C.S. Craft, T.J. Broekelmann, R.P. Mecham, and S.L. Teitelbaum. 2010. Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts. J. Cell Sci. 123:2955-2963. http://dx.doi.org/10.1242/jcs.069872.
26. Zou, W., T. Izawa, T. Zhu, J. Chappel, K. Otero, S.J. Monkley, D.R. Critchley, B.G. Petrich, A. Morozov, M.H. Ginsberg, and S.L. Teitelbaum. 2013. Talin1 and Rap1 are critical for osteoclast function. Mol. Cell. Biol. 33: 830-844. http://dx.doi.org/10.1128/MCB.00790-12.